av/formycon-ag--big.svg

COM:FORMYCON

Formycon AG

  • Stock

EUR

Last Close

46.85

25/11 09:20

Market Cap

965.83M

Beta: -

Volume Today

519

Avg: -

  • name

    Formycon AG
  • homepage url

    www.formycon.com
  • country

    DEGermany
  • employee count

    238
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    82.06M
  • monthly webtraffic

    6.53K
  • monthly webtraffic growth

    43.75%

Description

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate t...Show More

peer of

competitor of